Detalhe da pesquisa
1.
Innovative spiral electrode configuration for enhancement of electrocoagulation-flotation.
J Environ Manage
; 347: 119085, 2023 Dec 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37757685
2.
Identification of a modified coagulation factor X with enhanced activation properties as potential hemostatic agent.
Blood Cells Mol Dis
; 89: 102570, 2021 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-33962291
3.
FXIIa inhibitor rHA-Infestin-4: Safe thromboprotection in experimental venous, arterial and foreign surface-induced thrombosis.
Br J Haematol
; 173(5): 769-78, 2016 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-27018425
4.
The G534E polymorphism of the gene encoding the factor VII-activating protease is associated with cardiovascular risk due to increased neointima formation.
J Exp Med
; 203(13): 2801-7, 2006 Dec 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-17145954
5.
Increased potency of recombinant VWF D'D3 albumin fusion proteins engineered for enhanced affinity for coagulation factor VIII.
J Thromb Haemost
; 19(11): 2710-2725, 2021 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-34333849
6.
FVIII half-life extension by coadministration of a D'D3 albumin fusion protein in mice, rabbits, rats, and monkeys.
Blood Adv
; 4(9): 1870-1880, 2020 05 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-32374879
7.
Genetic fusion to albumin improves the pharmacokinetic properties of factor IX.
Thromb Haemost
; 102(4): 634-44, 2009 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-19806248
8.
Prolonged in-vivo half-life of factor VIIa by fusion to albumin.
Thromb Haemost
; 99(4): 659-67, 2008 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-18392323
9.
The Coagulation Factor XIIa Inhibitor rHA-Infestin-4 Improves Outcome after Cerebral Ischemia/Reperfusion Injury in Rats.
PLoS One
; 11(1): e0146783, 2016.
Artigo
em Inglês
| MEDLINE | ID: mdl-26815580
10.
Marburg I polymorphism of factor VII--activating protease: a prominent risk predictor of carotid stenosis.
Circulation
; 107(5): 667-70, 2003 Feb 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-12578864
11.
Non-clinical pharmacokinetics and pharmacodynamics of rVIII-SingleChain, a novel recombinant single-chain factor VIII.
Thromb Res
; 134(1): 125-31, 2014 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-24814969
12.
Preclinical efficacy and safety of rVIII-SingleChain (CSL627), a novel recombinant single-chain factor VIII.
Thromb Res
; 132(2): 280-7, 2013 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-23830969
13.
Structure-function analysis of factor VII activating protease (FSAP): sequence determinants for heparin binding and cellular functions.
FEBS Lett
; 583(12): 1994-8, 2009 Jun 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-19446554
14.
Technical considerations for the performance of Nucleic acid Amplification Technology (NAT). The NAT Task Force Group.
Biologicals
; 31(3): 153-9, 2003 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-12935802
15.
Hepatitis A virus prevalence in plasma donations.
J Med Virol
; 67(4): 469-71, 2002 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-12115990